Exchange Traded Fund (EMWE) News

I don't understand how going to the patent office would help, as they would have to correct the 048 to C1-C12 IMHO. Correcting 953 to C2-C12 wouldn't help as they would have no claim against C1. That correction would have had to have been made before 953 was filed to supersede it???

Same Yorkville Advisors? https://www.forbes.com/sites/nathanvardi/2012/10/17/sec-charges-formerly-1-billion-yorkville-advisors-hedge-fund-with-fraud-and-bogus-valuations/

Damn !!! Most respect to you 

Better modulators have a place - very possibly with Global Foundries, just as Lightmatter does.

And it is possible they can have a significant place within the modulator device world.

But there are many other technologies out there - including other photonic technologi

Private investors are buying the company out

$NVDA Top Bearish Flow – Open...
By: Peter DiCarlo | December 26, 2024

• Top Bearish Flow – Open

TSLA – $22.78M
NVDA – $11.11M
AAPL – $3.75M
META – $1.33M
MSTR – $1.23M

pbs.twimg.com/media/GfvBYNvWkAARD9R?

geminia ai pro says:"carrier frequency and teleportation




You're thinking in a very creative and abstract way! While carrier frequency and teleportation might seem unrelated at first glance, there are some intriguing connections and potential parallels, particu

RDAR looks ready to run on heavy volume...

$ILLR Upcoming announcement of the biggest combat championship in the world.

$AMD Top Bearish Flow – Open...
By: Peter DiCarlo | December 26, 2024

• Top Bearish Flow – Open

TSLA – $22.78M
NVDA – $11.11M
AAPL – $3.75M
META – $1.33M
MSTR – $1.23M

pbs.twimg.com/media/GfvBYNvWkAARD9R?f

"Short-Squeeze Target Anavex Life Sciences Gains Traction"
Story by Thomas Hughes, MarketBeat • 3h

Anavex Life Sciences (NASDAQ: AVXL) is a short-squeeze candidate because its share prices are rising on good news, institutional and analyst support is growing, and the short-sell

carrier frequency and teleportation




You're thinking in a very creative and abstract way! While carrier frequency and teleportation might seem unrelated at first glance, there are some intriguing connections and potential parallels, particularly when we conside

Did you really read hundreds of papers related to DCVax-L? The other day a self-claimed Ph.D. in biochemistry wrote a hit piece which is full of nonsense.

If you read so many papers, you should have known what exactly makes DCVax-L so unique and amazing and you should have known that

$10.80 on the way to $12 again target 

We are on target to have another great year. We are on target to skip the sixties and go for the seventies. This is going to be another record breaking year for us. Our growth cycle continues and it will be even stronger starting in calendar year 2025 and beyond. Our stock price now reflects our cur

Very Bullish 2025 RDAR

#1 2025 Stock To Buy Before 12/31/24. #Stocks #StockMarket $RDAR s Compound Annual Growth Rate Projected To Skyrocket $700 Mill. Euros in 2027 equals $728,423,068. Mill. USD

NWBO now has $50M backstop giving them a longer runway to automated production and strong revenue generation. There's no "bending over backwards." LP will be in control of partnership negotiations, holding what she holds.

RDAR looks ready to run on heavy volume...

12-26 B EDIT $1.17

BP provides their drug in a lot of trials. NWBO on the other hand can't even supply their own drug. That's why NWBO can't even PR what UCLA is doing because it isn't NWBO who is providing it. There will be no PR/investment from BP on anything related to NWBO.

Ho …. The answer to your missing financials from 2016 and 2017 can easily be found in a quick skim through of the company history. You are spreading false information. Why are you doing this?

$ILLR Upcoming announcement of the biggest combat championship in the world

$ILLR Strategic Partnerships
🤝 Building alliances: Recent partnerships with industry leaders will drive adoption, increase visibility, and solidify the company’s position in the market.

In order for them to be correct, it stands to reason that the first in line should fall into place. The first "prediction" is a release on January 20th. Well, I hate to be the bearer of bad news, but there will be NO release on that date, and likely not this year.

San Diego Living is the new Larry Bird Legend it seems.